Parasympathetic autonomic dysfunction is common in mild cognitive impairment.

Area of Science:

• Neuroscience
• Cardiology
• Gerontology

Background:

• Alzheimer's disease (AD) involves neurodegeneration in the central autonomic network, affecting areas like the insular cortex and brainstem early on.
• Acetylcholine deficiency, a neurotransmitter crucial for the parasympathetic system, may occur in mild cognitive impairment (MCI).
• Autonomic dysfunction presents a potential novel biomarker for neurodegeneration.

Purpose of the Study:

• To investigate autonomic function in individuals with MCI.
• To determine the association between autonomic dysfunction and neuropsychiatric deficits in MCI.
• To explore autonomic dysfunction as an early indicator of neurodegeneration in Alzheimer's disease.

Main Methods:

• An observational study involving 97 MCI participants and 36 controls.
• Assessment of autonomic function using bedside cardiovascular reflex tests and heart rate variability.
• Examination of the correlation between dysautonomia and neuropsychological deficits.

Main Results:

• MCI participants exhibited significant parasympathetic deficits compared to controls.
• Greater autonomic dysfunction correlated with more severe neuropsychological deficits.
• MCI participants were over 5 times more likely to have autonomic dysfunction than controls.

Conclusions:

• Autonomic dysfunction, especially parasympathetic, is prevalent in MCI, likely due to early central autonomic network changes in AD.
• This dysfunction may accelerate cognitive decline through inflammation or reduced cerebral blood flow.
• Identifying autonomic dysfunction could lead to new therapeutic strategies for cognitive decline.